184 related articles for article (PubMed ID: 35238249)
1. Hepatitis C Epidemiology in a Large Urban Jail: A Changing Demographic.
Hoff E; Warden A; Taylor R; Nijhawan AE
Public Health Rep; 2023; 138(2):248-258. PubMed ID: 35238249
[TBL] [Abstract][Full Text] [Related]
2. Correlates of Hepatitis C Virus Infection in the Targeted Testing Program of the New York City Jail System.
Akiyama MJ; Kaba F; Rosner Z; Alper H; Kopolow A; Litwin AH; Venters H; MacDonald R
Public Health Rep; 2017; 132(1):41-47. PubMed ID: 28005477
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C Virus Infection in the Dallas County Jail: Implications for Screening, Prevention, and Linkage to Care.
Abe CM; Aguwa M; Zhao M; Sullivan J; Porsa E; Nijhawan AE
Public Health Rep; 2019; 134(6):626-633. PubMed ID: 31530093
[TBL] [Abstract][Full Text] [Related]
4. Opt-out HIV and Hepatitis C Testing at the Dallas County Jail: Uptake, Prevalence, and Demographic Characteristics of Testers.
de la Flor C; Porsa E; Nijhawan AE
Public Health Rep; 2017; 132(6):617-621. PubMed ID: 29045799
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of infection with hepatitis B and C viruses and co-infection with HIV in three jails: a case for viral hepatitis prevention in jails in the United States.
Hennessey KA; Kim AA; Griffin V; Collins NT; Weinbaum CM; Sabin K
J Urban Health; 2009 Jan; 86(1):93-105. PubMed ID: 18622707
[TBL] [Abstract][Full Text] [Related]
6. Establishing an Epidemiologic Profile of Hepatitis C Virus Infection at the Los Angeles County Jail.
Qureshi N; Tadesse M; Tran N; Henderson S
Public Health Rep; 2021; 136(6):726-735. PubMed ID: 33602004
[TBL] [Abstract][Full Text] [Related]
7. A systematic review and meta-analysis of racial and ethnic disparities in hepatitis C antibody prevalence in United States correctional populations.
Larney S; Zaller ND; Dumont DM; Willcock A; Degenhardt L
Ann Epidemiol; 2016 Aug; 26(8):570-578.e2. PubMed ID: 27480479
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C antibody reactivity among high-risk rural women: opportunities for services and treatment in the criminal justice system.
Strickland JC; Staton M; Leukefeld CG; Oser CB; Webster JM
Int J Prison Health; 2018 Jun; 14(2):89-100. PubMed ID: 29869584
[TBL] [Abstract][Full Text] [Related]
9. Strategies to identify hepatitis C virus infection in patients receiving anticancer therapy: a cross-sectional study.
Torres HA; Lok AS; Suarez-Almazor ME; Warneke CL; Kaseb A; Miller E; Sturgis EM; Foreman JT; Angelidakis G; Ahmed S; Ferrajoli A; Samaniego F; Hawk ET; Hwang JP
Support Care Cancer; 2021 Jan; 29(1):97-105. PubMed ID: 32314052
[TBL] [Abstract][Full Text] [Related]
10. Sociodemographic and clinical characteristics of persons who experienced spontaneous hepatitis C viral clearance.
Kimble MM; Javanbakht M; Chew KW; Stafylis C; He D; Ramirez S; Baik Y; Saab S; Klausner JD
BMC Infect Dis; 2019 Jul; 19(1):626. PubMed ID: 31307403
[TBL] [Abstract][Full Text] [Related]
11. Results of Hepatitis C Birth-Cohort Testing and Linkage to Care in Selected U.S. Sites, 2012-2014.
Patel RC; Vellozzi C; Smith BD
Public Health Rep; 2016; 131 Suppl 2(Suppl 2):12-9. PubMed ID: 27168656
[TBL] [Abstract][Full Text] [Related]
12. High Hepatitis C Infection Rate Among Baby Boomers in an Urban Primary Care Clinic: Results from the HepTLC Initiative.
Geboy AG; Mahajan S; Daly AP; Sewell CF; Fleming IC; Cha HA; Perez IE; Cole CA; Ayodele AA; Fishbein DA
Public Health Rep; 2016; 131 Suppl 2(Suppl 2):49-56. PubMed ID: 27168662
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C Virus Testing and Linkage to Care in North Carolina and South Carolina Jails, 2012-2014.
Schoenbachler BT; Smith BD; Seña AC; Hilton A; Bachman S; Lunda M; Spaulding AC
Public Health Rep; 2016; 131 Suppl 2(Suppl 2):98-104. PubMed ID: 27168668
[TBL] [Abstract][Full Text] [Related]
14. Assessment of hepatitis C risk factors and infection prevalence in a jail population.
Wenger PJ; Rottnek F; Parker T; Crippin JS
Am J Public Health; 2014 Sep; 104(9):1722-7. PubMed ID: 25033142
[TBL] [Abstract][Full Text] [Related]
15. Prevalence, estimated incidence, risk behaviours, and genotypic distribution of hepatitis C virus among people who inject drugs accessing harm-reduction services in Kenya: a retrospective cohort study.
Akiyama MJ; Cleland CM; Lizcano JA; Cherutich P; Kurth AE
Lancet Infect Dis; 2019 Nov; 19(11):1255-1263. PubMed ID: 31540840
[TBL] [Abstract][Full Text] [Related]
16. Anti-Hepatitis C (HCV) test positivity and new HCV diagnoses among women tested in antenatal services in England between 2015-2019.
Hibbert M; Simmons R; Mandal S; Sabin CA; Desai M
Midwifery; 2023 Dec; 127():103863. PubMed ID: 37931465
[TBL] [Abstract][Full Text] [Related]
17. A simple strategy to identify acute hepatitis C virus infection among newly incarcerated injection drug users.
Kim AY; Nagami EH; Birch CE; Bowen MJ; Lauer GM; McGovern BH
Hepatology; 2013 Mar; 57(3):944-52. PubMed ID: 23111904
[TBL] [Abstract][Full Text] [Related]
18. Racial differences in testing for infectious diseases: An analysis of jail intake data.
Wurcel AG; Guardado R; Grussing ED; Koutoujian PJ; Siddiqi K; Senst T; Assoumou SA; Freund KM; Beckwith CG
PLoS One; 2023; 18(12):e0288254. PubMed ID: 38117818
[TBL] [Abstract][Full Text] [Related]
19. Correlates of hepatitis C virus (HCV) RNA negativity among HCV-seropositive blood donors.
Busch MP; Glynn SA; Stramer SL; Orland J; Murphy EL; Wright DJ; Kleinman S;
Transfusion; 2006 Mar; 46(3):469-75. PubMed ID: 16533292
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C Virus Infection Screening Within Community Health Centers.
Cook N; Turse EP; Garcia AS; Hardigan P; Amofah SA
J Am Osteopath Assoc; 2016 Jan; 116(1):6-11. PubMed ID: 26745559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
